Next Article in Journal
RNAseq Analysis of Livers from Pigs Treated with Testosterone and Nandrolone Esters: Selection and Field Validation of Transcriptional Biomarkers
Next Article in Special Issue
Investigating the Impact of Varied Dietary Protein Levels on Litopenaeus vannamei: An Exploration of the Intestinal Microbiota and Transcriptome Responses
Previous Article in Journal
The Effect of Replacing Whole-Plant Corn Silage with Daylily on the Growth Performance, Slaughtering Performance, Muscle Amino Acid Composition, and Blood Composition of Tan Sheep
Previous Article in Special Issue
Differences in Faecal Nutritional Components in Three Species of Saharan Gazelles on Standard Diets in Relation to Species, Age and Sex
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Glucose Levels on Inflammation and Amino Acid Utilization in Lipopolysaccharide-Induced Bovine Mammary Epithelial Cells

College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
*
Author to whom correspondence should be addressed.
Animals 2023, 13(22), 3494; https://doi.org/10.3390/ani13223494
Submission received: 14 September 2023 / Revised: 28 October 2023 / Accepted: 6 November 2023 / Published: 13 November 2023
(This article belongs to the Special Issue Comparative Animal Nutrition and Metabolism)

Abstract

:

Simple Summary

Inflammation of bovine mammary epithelial cells (BMECs) may occur during mastitis, which affects the nutrient absorption, metabolism, and glucose and amino acid utilization of mammary epithelial cells. However, there are few studies on amino acid uptake under different nutritional conditions. Therefore, the aim of this study was to investigate the effects of lipopolysaccharide (LPS) on nutrient transport and metabolic energy supply under high- and low-glucose conditions by evaluating glucose and amino acid consumption and the expression of related genes, and to examine how different concentrations of glucose affect the proinflammatory response. BMECs were cultured in 6-well culture plates with different concentrations of glucose with or without 4 μg/mL LPS for 6 h, and then the consumption of glucose and amino acids in the supernatant was detected and the relative expression of related mRNA was determined.

Abstract

Glucose and amino acids are important sources of nutrients in the synthetic milk of dairy cows, and understanding the fate of amino acids is essential to optimize the utilization of amino acids in milk protein synthesis, thereby reducing nutrient inefficiencies during lactation. The purpose of this study was to investigate the effects of LPS and different concentrations of glucose on (1) the expression of inflammatory factors and genes, (2) the glucose metabolism, and (3) amino acid utilization in BMECs. The results showed that there was an interaction (LPS × glucose, p < 0.05) between LPS and glucose content in the inflammatory cytokine genes (IL-6 and TNF-α) and the inflammatory regulatory genes (CXCL2, CXCL8, and CCL5). With the addition of LPS, the HG + LPS group caused downregulated (p < 0.05) expression of IL-6 and TNF-α, compared with the LG + LPS group. Interestingly, compared with the LG + LPS group, the HG + LPS group upregulated (p < 0.05) the expression of CXCL2, CXCL8, and CCL5. LPS supplementation increased (p = 0.056) the consumption of glucose and GLUT1 gene expression (p < 0.05) and tended to increase (p = 0.084) the LDHA gene expression of BMECs under conditions of different concentrations of glucose culture. High glucose content increased (p < 0.001) the consumption of glucose and enhanced (p < 0.05) the GLUT1, HK1, HK2, and LDHA gene expression of BMECs with or without LPS incubation, and there was an interaction (LPS × glucose, p < 0.05) between LPS and glucose concentrations in GLUT1 gene expression. In this study, LPS enhanced (p < 0.05) the consumption of amino acids such as tryptophan, leucine, isoleucine, methionine, valine, histidine, and glutamate, while high levels of glucose decreased (p < 0.01) consumption, except in the case of tyrosine. For histidine, leucine, isoleucine, and valine consumption, there was an interaction (LPS × glucose, p < 0.05) between LPS and glucose levels. Overall, these findings suggest that relatively high glucose concentrations may lessen the LPS-induced BMEC inflammatory response and reduce amino acid consumption, while low glucose concentrations may increase the demand for most amino acids through proinflammatory responses.

1. Introduction

Mastitis, an inflammation of the bovine mammary glands caused by changes in metabolism, environmental pathogenic microorganisms, or contagion, is one of the costliest diseases of dairy cows. Invasive pathogens are the leading cause of mastitis. Staphylococcus aureus and Escherichia coli (E. coli) are the two most important culprit pathogens causing mastitis in cattle [1]. Bovine mammary innate immunity relies on host cell pattern recognition receptors binding pathogen-associated molecular patterns, such as lipopolysaccharide (LPS) from E. coli [2,3,4]. LPS-induced bovine mammary epithelial cells (BMECs) have also been reported to increase a proinflammatory response [5,6].
Several interconnected metabolic perturbations accompany inflammation. During inflammation, the immune response increases nutrient consumption of amino acids, energy substrates, and micronutrients [7]. Our previous study demonstrated that inflammation decreased the ketogenesis-related gene expression in bovine ruminal epithelial cells [8]. In particular, glucose demand is enhanced by the immune response [9]. Kvidera et al. [10] reported that dairy cows challenged with systemic LPS exhibited extra utilization of at least 1 kg of glucose. Intramammary LPS in dairy cows increased their glucose consumption from 150 to 270 min after LPS infusion [11], which indicated that the higher glucose requirement is associated with increased hepatic glycogenolysis and gluconeogenesis, leading to an initial hyperglycemic state [12,13]. Therefore, the activation of the immune response consumes energy substrates. However, little is known about the relationship between metabolic adaptations and immune responses in dairy cows.
Glucose is a vital nutrient for all species but is especially pertinent to lactating dairy cows. Glucose generates Adenosine triphosphate via glycolysis and the Krebs cycle [14,15]. Amid the negative energy balance (NEB), glucose concentration is difficult to maintain in the inflammatory state [16]. Nevertheless, evidence indicates that amino acids play an essential role as substrates for energy metabolism and biosynthetic activities [17,18,19,20,21]. Glucose deficiency in the brain appears to increase the utilization of aminos as alternative energy substrates [22]. The mammary glands reduce milk protein synthesis, primarily of glucose and amino acids in dairy cows [23], in response to immune response [24,25]. However, few studies have investigated the potential effects of inflammation on BMECs [26,27,28]. In the present study, we hypothesized that amino acids might compensate for glucose deficiency during an activated immune response. However, the effects of glucose and inflammation on the cost of amino acids is unknown. Therefore, this study aimed to determine the effects of LPS and glucose on inflammatory response and amino acid utilization in BMECs.

2. Materials and Methods

All trials, plans, and methods were authorized by the Animal Ethics Committee of Yangzhou University, China. The study was conducted under the Care and Use of Laboratory Animals guidelines.

2.1. Experimental Design and Treatment

To explore the role of glucose in innate immunity and the content of amino acids, we prepared mammary gland tissues from three healthy Holstein dairy cows in mid lactation, which came from the Institute of Animal Culture Collection and Application, Yangzhou University. These tissues were respectively digested for 3 h by collagenase type I (Invitrogen, Shanghai, China), and cells were filtered using nylon mesh (75 μm) to obtain the BMECs. The BMECs that were isolated and cultured are described by Zhan et al. [29]. Briefly, treatments were arranged in a 2 × 2 factorial design with or without LPS (4 μg/mL) and with glucose levels of 17.5 mM (HG) or 2.5 mM (LG), and treatment groups were LG group, LG + LPS group, HG group, and HG + LPS group. In this study, LPS came from E. coli O55:B5 lyophilized powder (L6529, Sigma-Aldrich, St. Louis, MO, USA). The concentration of glucose was referenced in a previous study [30]. The BMECs were cultured for 12 h and then starved with Dulbecco’s Modified Eagle Medium (DMEM)/F12 without serum and glucose for 6 h. After the culture was finished, 4 μg/mL LPS was added to the culture medium containing the above two concentrations of glucose for 6 h. After culturing, the supernatant was collected to determine the content of amino acids and glucose, and the relative mRNA expression in the cells was detected using Quantitative Real-Time PCR (qRT-PCR).

2.2. qRT-PCR

The cells were seeded into 6-well plates at a density of 2 × 105 cells/well for mRNA expression analysis. Following incubation, total RNA was extracted from incubated cells with the aid of the FastPure Cell/Tissue Total RNA Isolation Kit (RC101, Vazyme Biotech Co., Ltd., Nanjing, China) per the supplier’s directives. RNA purity and concentration were determined using an OD-1000 + Micro-Spectrophotometer, and RNA quality was verified via a 2% agarose gel electrophoresis. The OD260/280 proportion of the total RNA was revealed to be 1.9 in this research study, and the intensity of the 28S ribosomal RNA band in total RNA samples was nearly two times that of the 18S ribosomal RNA band, denoting that the total RNA was of great quality. Reverse transcription was accomplished via a reverse transcription kit (Takara, Beijing, China). In a final volume of 20 µL, the reverse transcription reaction mixtures’ constituents were 1 µg of total RNA and 1 PrimeScript reverse transcription Master Mix, and the reactions were conducted at 37 °C for 15 min. Reverse transcriptase was neutralized thermally for 5 s at 85 °C. The SYBR® Premix Ex TaqTM II Kit (Takara) was employed for the qRT-PCR assays. In a final volume of 20 µL, the qRT-PCR reaction mixture comprised 1 SYBR® Premix Ex TaqTM II, forward and reverse primers at 0.4 µM, and 100 ng of cDNA templates, and the reactions were carried out as follows: initial denaturation for 30 s at 95 °C, preceded by 40 cycles for 5 s at 95 °C and for 30 s at 60 °C. Before running the samples using qRT-PCR, primers were fabricated to span exon–exon junctions whenever likely, and dimer inception was assessed via the creation of melt curves subsequent to amplification to validate the existence of a lone end product. Table 1 lists the primers that were used. A negative control reaction was carried out without a cDNA sample. RefFinder (http://blooge.cn/RefFinder/ accessed on 18 March 2023), which includes Normfinder, geNorm, and the comparative ΔCT method, was used to determine the rankings of the candidate genes and the selection of the first-rank reference gene (ACTB, RPS9, and GAPDH). The ultimate ranking was determined by means of allocating an appropriate weight value to every gene and confirming the total final ranking via the geometric mean of their weight values. A lower gene geomean of ranking value was indicative of a higher expression stability. Finally, GAPDH was screened for subsequent study. The results were analyzed by using the 2−ΔΔCt method, which quantifies the fold changes in mRNA levels of targeted genes [31]. All trials had three replicates.

2.3. Chromatographic Conditions

The standard amino acid mixture with a concentration of 2 mmol/L of each amino acid was prepared.
Preparation of mobile phase A was as follows: weigh 8.203 g anhydrous sodium acetate, add 930 mL ultra-pure water, stir to dissolve, adjust the pH of ice acetic acid to 6.5, add 70 mL acetonitrile, mix and filter with 0.22 μm filter membrane, follow with ultrasonic degassing for 15 min. Preparation of mobile phase B was as follows: accurately measure 800 mL acetonitrile solution, add 100 mL methanol solution and 100 mL ultra-pure water, thoroughly mix, filter with 0.22 μm organic-phase filter membrane, follow with ultrasonic degassing for 15 min.
The flow rate of gradient elution was 0.7 mL/min, the column temperature was 40 °C, and the detection wavelength was 254 nm. The samples were analyzed using Waters 1525 Binary High-Performance Liquid Chromatography Pump and Waters 2998 Photodiode Array Detector with SunFireTM C18 column (4.6 mm × 250 mm, 5 μm).
Preparation of phenyl isothiocyanate acetonitrile solution was as follows: accurately measure 50 μL phenyl isothiocyanate, add 4 mL acetonitrile, shake and mix.
Preparation of triethylamine acetonitrile solution was as follows: accurately measure 1.4 mL triethylamine solution and add acetonitrile for 8.6 mL.
Derivative of amino acid mixed standard was achieved as follows: place 200 μL mixed amino acids standard in 1.5 mL centrifuge tube, and accurately add 20 μL norleucine internal standard solution, 100 μL phenyl isothiocyanate acetonitrile solution, and 100 μL triethylamine acetonitrile solution, swirling for 15 s, and leave at room temperature for 1 h. After the derivatization, add 400 μL n-hexane, cover tightly, swirl for 30 s, stand at room temperature for 15 min, take the lower solution, filter through 0.22 μm organic-phase filter membrane, take 200 μL filtrate and add 800 μL filtered ultra-pure water, mix well, absorb 10 μL for detection.
The operation of the sample cell supernatant is the same as that of standard amino acid mixtures.

2.4. Statistical Analysis

Data generated were subjected to two-way ANOVA analysis, and the statistical model included the effects of LPS and glucose. Statistical significance was set at p < 0.05. A post hoc test was conducted using Bonferroni’s multiple comparison test (p < 0.05) for significant interactions. The experiments were conducted in triplicate, and all experiments were repeated at least three times. Prior to conducting the ANOVA, Levene’s test was used to ensure that the assumption of homogeneity of variances was met (p > 0.05).

3. Results

3.1. Effects of LPS and Glucose on Inflammation Regulation and Inflammatory Cytokine Gene Expression of BMECs

Our data showed that the interaction between the levels of LPS and glucose affected IL-6 and TNF-α gene expression, as shown in Figure 1B,C (LPS × glucose, p < 0.001). The LG + LPS and HG + LPS groups increased in IL-6 and TNF-α mRNA expression (p < 0.05), and the HG group did not show any effect in the gene expression of IL-6 and TNF-α compared to the LG group. Interestingly, HG + LPS decreased the gene expression of IL-6 and TNF-α compared to the LG + LPS group (p < 0.05).
For the expression of CXCL2, CXCL8, and CCL5, chemokines recruited neutrophils during the inflammation response (Figure 1D,F,G). Compared with the LG group, the LG + LPS and HG groups increased their gene expressions of CXCL2, CXCL8, and CCL5, and the highest expression of CXCL2, CXCL8, and CCL5 occurred in the HG + LPS group (LPS × glucose, p < 0.05). A tendency for the same response also showed up in CXCL6 (Figure 1E, LPS × glucose, p = 0.406), while the LG + LPS, HG, and HG + LPS groups increased their expressions of CXCL6 compared with the LG group.

3.2. Effects of LPS and Glucose on Glucose Metabolism of BMECs

The expression of GLUT8 was not affected by LPS or glucose (Figure 2B, LPS × glucose, p = 0.536). However, the LPS-induced BMECs increased the mRNA expression of GLUT1 (Figure 2A, LPS × glucose, p < 0.05), which is consistent with an increase in glucose utilization. Higher glucose level without LPS led to an upregulation of GLUT1 (p < 0.001). The LG + LPS, HG, and HG + LPS groups increased their expressions of GLUT1 (p < 0.05), and the highest expression of GLUT1 occurred in the HG + LPS group, compared with the LG group. Furthermore, there was an interaction between LPS and glucose that affected GLUT1 gene expression (LPS × glucose, p < 0.05), which seems to support the HG group’s increased glucose utilization.
Our data showed that LPS did not affect the gene expression of HK1 (p = 0.332) and HK2 (p = 0.871), as shown in Figure 2C,D, but the incubation of glucose levels affected the mRNA expression of HK1 (p < 0.01) and HK2 (p < 0.05), and the interaction between LPS and glucose levels did not affect the gene expression of HK1 (LPS × glucose, p = 0.496) and HK2 (LPS × glucose, p = 0.513). Compared with the LG group, the HG group increased its mRNA expression of HK1 (p < 0.05) and HK2 (p < 0.05). Under HG conditions, there was the presence an LPS trend to decrease the gene expression of HK2 (p = 0.068). However, under LG conditions, LPS did not affect the gene expression of HK1, while it had a tendency to increase the expression of HK2 (p = 0.068).
For LDHA gene expression (Figure 2E), LPS-induced BMECs had an upward tendency (p = 0.084), while the high concentration of glucose increased (p < 0.05). The LG + LPS group and the HG group had a rising trend (p = 0.052), while the HG + LPS group enhanced its expression (p < 0.05) of LDHA compared with the LG group.
The glucose uptake results are shown in Figure 2F. The concentration of glucose affected glucose consumption (p < 0.001), while there was a tendency to increase glucose consumption through the addition of LPS (p = 0.056). The amount of glucose consumed increased in the HG and HG + LPS groups (p < 0.05), and the highest amount of glucose consumed was in the HG + LPS group, compared with the LG group (LPS × glucose, p = 0.980).

3.3. Effects of LPS and Glucose on Amino Acid Utilization of BMECs

To elucidate the depletion of amino acids due to inflammation and low glucose, we tested the amino acid content in the supernatant (Table 2). The interactions between LPS and the different levels of glucose affected (LPS × glucose, p < 0.05) histidine and branched-chain amino acids (BCAAs), such as leucin, isoleucine, and valine. Compared with the LG group, the LG + LPS group increased (p < 0.05) its consumption of histidine, leucin, isoleucine, and valine, while that of the HG and HG + LPS groups was reduced (p < 0.05). LPS incubation can take away more amino acids (p < 0.05), such as tryptophane, leucin, isoleucine, methionine, valine, histidine, and glutamate. Higher levels of glucose decreased (p < 0.01) their consumption, except for tyrosine, and the HG group consumed the fewest amino acids.

4. Discussion

The innate immune system represents the first line of defense in the host’s response to infection and is prepared to immediately recognize and respond to the early stages of infection [32,33]. A key component of the host’s innate immune response to infection is the upregulation of cytokine production [34,35]. IL-6 is an essential inflammatory mediator that appears to be a similar marker of early inflammation and prognosis in several diseases [36]. TNF-α is an extremely proinflammatory cytokine with injurious properties [37]. One of the most common pathogenic microorganisms causing severe acute inflammatory response leading to mastitis is E coli [38], which is a gram-negative bacterium. LPS is one of the most important components of the outer wall of gram-negative bacteria, which can cause inflammation in BMECs [39]. In this study, LPS-induced BMECs increased the expression of IL-1β, IL-6, and TNF-α, which is consistent with previous studies [40,41]. Zhang et al. [42] demonstrated that after BMECs were induced with LPS, the mRNA expression of TNF-α was significantly increased at all glucose concentrations, especially at low glucose concentrations, which is consistent with our results. Glucose plays a vital role in immunity; inflammation can increase catabolism and enhance glucose and amino acid demand in the bovine mammary gland [43,44,45]. Activated inflammation response enhances whole-body glucose requirements [10]. Inflammation is a biological response of the immune response. Activation of the immune response is characterized by decreased milk synthesis, maybe due to immune system nutrient consumption [23,24], especially of glucose and amino acids, in dairy cows [25]. The mammary gland is uniquely designed for the valid uptake and metabolism of nutrients, especially glucose. Furthermore, the mammary gland is the organ that consumes the most glucose [46]. Inadequate nutrient uptake and simultaneously high milk production levels may lead to an NEB in dairy cows [47,48]. The NEB takes place in the transition period until week 7 to 9 postpartum in dairy cows [49,50]. It is generally assumed that typical endocrine and metabolic adaptations occur during the NEB [48]. In addition, the immune system is impaired during periods of NEB, and the vast majority of production diseases, including mastitis, reach the greatest risk level during the transition period [51,52]. Moreover, periparturient cows are faced with more rapid bacterial growth, greater peak bacterial concentrations, and higher proinflammatory cytokine concentrations in the foremilk than mid-lactation cows [53]. However, during the NEB, glucose is maintained at lower levels, frequently accompanied by perturbation of the immune response in cattle and persistence of bacterial infections in the mammary glands, resulting in mastitis [52]. Clearance of these bacteria from the breast relies on a rapid and strong innate immune response, including the secretion of cytokines such as IL-1β and IL-6 and chemokines such as IL-8, which attract neutrophils to the site of infection [54]. In this research, LPS-induced BMECs which were cultured in high levels of glucose decreased the expression of inflammation-related genes such as IL-6 and TNF-α. This may be because higher levels of glucose are used more by immune cells to alleviate inflammation [10]. Similar research found that the addition of rumen-protected glucose could reduce the incidence of inflammation in dairy cows [55]. In the present study, higher concentrations of glucose enhanced the expression of some chemokines, such as CXCL2, CXCL8, and CCL5, while CXCL6 gene expression was also increased without a significant difference. During bovine mastitis, chemokines can recruit neutrophils to the mammary gland infected by the pathogen to relieve the inflammatory response and eliminate the pathogen [56,57]. Therefore, recruited neutrophils play a vital role in the resolution of mastitis. The present study showed that glucose was able to modulate the inflammatory response to LPS in BMECs and may further affect cellular processes or metabolism.
Glucose is vital in virtually all organisms, especially in dairy cows. Importantly, the vast majority of the glucose that is present in the blood of the lactating cow is used for lactose synthesis by the mammary gland during lactation [58] because glucose is involved in lactose synthesis, and lactose determines the amount of milk by maintaining osmotic pressure [59]. At the same time, glucose is the main fuel for cellular energy, which generates ATP via glycolysis and the Krebs cycle. During the NEB, the concentration of glucose is difficult to maintain in an inflammatory state. However, this state is quickly exhausted after the inflammatory state. Therefore, glucose plays an important role in immune response. Zhao et al. [60] reported that 20 mM of glucose increased glucose uptake in BMECs, compared to a lower glucose level. In addition, the increase in glucose consumption found in the LPS-induced group indicated that inflammation activation shifts glucose toward glycolysis or oxidation [61]. To elucidate the mechanism of glucose utilization, we detected the expression of genes related to glucose metabolism. In the bovine mammary gland, both GLUT1 and GLUT8 are vital glucose transporters [62,63]. Our data showed that the expression of GLUT1 was enhanced in the HG group or with the addition of LPS, as in the LG + LPS and HG + LPS groups, compared with the LG group. Lin et al. [64] showed that compared with no glucose, 12 mM of glucose not only increased lactose content in BMECs but also increased the expression of genes involved in glucose transport, such as GLUT1, which may be due to the fact that GLUT1 is the main glucose transporter in BMECs for lactose synthesis, and its levels are regulated by glucose. In addition, GLUT1 may be important for regulating inflammation in the skin [65]. During inflammation-induced hypoxia, the expression of GLUT1 was enhanced, which induced the upregulation of glycolysis in inflammation sites [66,67], which is consistent with the higher gene expression of LDHA. The expression of GLUT8 mRNA was not affected by different concentrations of glucose, which is consistent with a previous study [60]. It is possible that a higher level of glucose enhances GLUT1 in part by increasing inflammatory activation. Hexokinase catalyzes glucose to glucose-6-phosphate as the first step in glycolysis. Xiao et al. [68] demonstrated that hexokinase may play a vitally important role in glucose metabolism in bovine mammary glands. In this study, high levels of glucose enhanced the expression of GLUT1 and HK1, which is consistent with some previous research (12 mM) [64]. With lower levels of glucose, there was no difference in HK1 and HK2 gene expression between groups with and without LPS treatment. This may be because glucose is quickly exhausted after the inflammatory state; therefore, a change in the gene expression of HK1 and HK2 may not have been detectable under LG conditions. Interestingly, LPS-induced BEMCs increased the expression of LDHA in both the LG and HG groups, which supports the claim that inflammation activation increases glucose metabolism toward glycolysis. In the present study, BMECs had a tendency to consume more glucose when stimulated by LPS. Similar findings have been found in buffalo; serum glucose concentrations in buffalo with subclinical mastitis were significantly lower than in healthy buffalo [69]. This may also be due to the fact that inflammation increases the consumption of glucose to reduce the concentration of glucose in the serum.
Amino acids have important physiological significance and are components of proteins and substrates for the synthesis of small molecules. BCAAs are important for maintaining inflammation response [70]. Furthermore, BCAAs can be converted to α-ketoisocaproate, α-ketoisovalerate, and α-keto-β-methylvalerate, and eventually they become an intermediate in the tricarboxylic acid cycles of cholesterols such as acetyl-CoA, acetoacetate, and succinyl-CoA [71]. During inflammation activation, BCAAs can be transaminated to glutamate in order to increase glutamine synthesis [71]; this may also indirectly explain why LPS-induced BMECs consume more glutamate. Glutamine is a vital fuel for the cells of the inflammation response, contributing to inhibition of apoptosis, protein synthesis, and activation of macrophage function [70], suggesting that BCAAs may have this effects on BMECs. Studies have also shown that leucin can decrease H2O2-induced BMEC injuries by producing more ATP for energy potential [72]. The concentration of BCAAs in the plasma of cows decreases before calving and reaches its lowest level on the day of calving due to the NEB [73,74], and inflammation is often challenged at this time. In addition, amino acids are important for the body’s immune function and recovery, but their supply tends to decrease during times of stress or inflammation [75]. Therefore, we supposed that LPS-induced BMECs have a high consumption of amino acids at low glucose concentrations. The results showed that BMECs consumed more BCAAs and histidine when cultured in low concentrations of glucose with or without the induction of LPS, and the BMEC consumption of amino acids induced by LPS was the highest in low concentrations of glucose culture. The most-consumed amino acids are BCAAs and histidine, which may convert to intermediates of the tricarboxylic acid cycle to compensate for the glucose deficit. When cows encounter an NEB, ketosis may occur due to insufficient energy. Similar studies have shown that serum leucine, histidine, and valine are reduced in cows with primary ketosis compared to healthy cows, but isoleucine and glutamate concentrations are increased, which is inconsistent with our results. This may be due to the use of amino acids for the synthesis of gluconeogenesis in response to inflammation and increased glucose demand [76], which may also be a better explanation for our results. In the present study, we found that reducing glucose intake greatly increased amino acid consumption, which is consistent with our hypothesis.

5. Conclusions

The present study demonstrated that inflammatory response affects glucose and amino acid transport and metabolism. Our results showed that BMECs consumed more glucose for glycolysis and BCAAs induced by LPS, presumably due to the proinflammatory response. Under stimulation with LPS, the addition of glucose showed a decrease in proinflammatory cytokines and an increased recruitment of immune cells, especially neutrophils. In defiance to glucose, amino acids may provide energy compensation. However, many questions still remain. In the current study, LPS-induced BMECs with different glucose levels increased mRNA GLUT1 expression and BCAA consumption as high glucose contents decreased. In addition, the exact role of BCAAs on inflammation activation was not fully elucidated. Future research should explain the mechanisms by which GLUT1 is involved in inflammation and glucose transport and whether BCAAs play a specific role in inflammation.

Author Contributions

Conceptualization, H.S.; methodology, H.S. and T.Y.; software, H.S.; validation, H.S. and T.Y.; formal analysis, H.S.; resources, X.M. and Y.C.; data curation, H.S. and M.J.; writing—original draft preparation, H.S. and T.Y.; visualization, Z.L. and K.Z.; funding acquisition, G.Z.; writing—review and editing, H.S. and O.D.; supervision, G.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the National Natural Science Foundation of China (No. 32372903) and the China Agriculture Research System of MOF and MARA (CARS-36).

Institutional Review Board Statement

The study received the approval of the Institutional Animal Care and Use Committee of Yangzhou University. The ethically approved project identification code is SYXK (Su) 2021-0026. All procedures were carried out under the guidelines and regulations stipulated in the experimental animal guidelines.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lahouassa, H.; Moussay, E.; Rainard, P.; Riollet, C. Differential cytokine and chemokine responses of bovine mammary epithelial cells to Staphylococcus aureus and Escherichia coli. Cytokine 2007, 38, 12–21. [Google Scholar] [CrossRef]
  2. Borges, Á.M.; Healey, G.D.; Sheldon, I.M. Explants of Intact Endometrium to Model Bovine Innate Immunity and Inflammation Ex Vivo. Am. J. Reprod. Immunol. 2012, 67, 526–539. [Google Scholar] [CrossRef]
  3. Cronin, J.G.; Turner, M.L.; Goetze, L.; Bryant, C.E.; Sheldon, I.M. Toll-Like Receptor 4 and MYD88-Dependent Signaling Mechanisms of the Innate Immune System Are Essential for the Response to Lipopolysaccharide by Epithelial and Stromal Cells of the Bovine Endometrium1. Biol. Reprod. 2012, 86, 1–9. [Google Scholar] [CrossRef] [PubMed]
  4. Grommers, F.J.; Van De Geer, D.; Van Der Vliet, H.; Henricks, P.A.J.; Nijkamp, F.P. Polymorphonuclear leucocyte function: Relationship between induced migration into the bovine mammary gland and in vitro cell activity. Vet. Immunol. Immunopathol. 1989, 23, 75–83. [Google Scholar] [CrossRef] [PubMed]
  5. Fu, Y.; Zhou, E.; Liu, Z.; Li, F.; Liang, D.; Liu, B.; Song, X.; Zhao, F.; Fen, X.; Li, D.; et al. Staphylococcus aureus and Escherichia coli elicit different innate immune responses from bovine mammary epithelial cells. Vet. Immunol. Immunopathol. 2013, 155, 245–252. [Google Scholar] [CrossRef]
  6. Zheng, L.; Xu, Y.; Lu, J.; Liu, M.; Dai, B.; Miao, J.; Yin, Y. Variant innate immune responses of mammary epithelial cells to challenge by Staphylococcus aureus, Escherichia coli and the regulating effect of taurine on these bioprocesses. Free Radic. Biol. Med. 2016, 96, 166–180. [Google Scholar] [CrossRef]
  7. Wolowczuk, I.; Verwaerde, C.; Viltart, O.; Delanoye, A.; Delacre, M.; Pot, B.; Grangette, C. Feeding Our Immune System: Impact on Metabolism. Clin. Dev. Immunol. 2008, 2008, 639803. [Google Scholar] [CrossRef] [PubMed]
  8. Yang, T.; Datsomor, O.; Jiang, M.; Ma, X.; Zhao, G.; Zhan, K. Protective Roles of Sodium Butyrate in Lipopolysaccharide-Induced Bovine Ruminal Epithelial Cells by Activating G Protein-Coupled Receptors 41. Front. Nutr. 2022, 9, 842634. [Google Scholar] [CrossRef] [PubMed]
  9. Kominsky, D.J.; Campbell, E.L.; Colgan, S.P. Metabolic Shifts in Immunity and Inflammation. J. Immunol. 2010, 184, 4062–4068. [Google Scholar] [CrossRef]
  10. Kvidera, S.K.; Horst, E.A.; Abuajamieh, M.; Mayorga, E.J.; Fernandez, M.V.S.; Baumgard, L.H. Glucose requirements of an activated immune system in lactating Holstein cows. J. Dairy Sci. 2017, 100, 2360–2374. [Google Scholar] [CrossRef] [PubMed]
  11. Waldron, M.R.; Kulick, A.E.; Bell, A.W.; Overton, T.R. Acute Experimental Mastitis Is Not Causal Toward the Development of Energy-Related Metabolic Disorders in Early Postpartum Dairy Cows. J. Dairy Sci. 2006, 89, 596–610. [Google Scholar] [CrossRef] [PubMed]
  12. Hartl, W.H.; Jauch, K.W. Metabolic self-destruction in critically ill patients: Origins, mechanisms and therapeutic principles. Nutrition 2014, 30, 261–267. [Google Scholar] [CrossRef] [PubMed]
  13. Maitra, S.R.; Wojnar, M.M.; Lang, C.H. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000, 13, 379–385. [Google Scholar] [CrossRef] [PubMed]
  14. Lunt, S.Y.; Vander Heiden, M.G. Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27, 441–464. [Google Scholar] [CrossRef] [PubMed]
  15. Newsholme, E.; Dimitriadis, G. Integration of biochemical and physiologic effects of insulin on glucose metabolism. Exp. Clin. Endocrinol. Diabetes 2001, 109, S122–S134. [Google Scholar] [CrossRef]
  16. Zhang, L.S.; Davies, S.S. Microbial metabolism of dietary components to bioactive metabolites: Opportunities for new therapeutic interventions. Genome Med. 2016, 8, 46. [Google Scholar] [CrossRef]
  17. Bradford, H.F.; Ward, H.K.; Thomas, A.J. Glutamine? A major substrate for never endings. J. Neurochem. 1978, 30, 1453–1459. [Google Scholar] [CrossRef] [PubMed]
  18. Tildon, J.T.; Roeder, L.M. Transport of 3-hydroxy[3-14C]butyrate by dissociated cells from rat brain. Am. J. Physiol.-Cell Physiol. 1988, 255, C133–C139. [Google Scholar] [CrossRef]
  19. Hassel, B.; Bachelard, H.; Jones, P.; Fonnum, F.; Sonnewald, U. Trafficking of Amino Acids between Neurons and Glia In Vivo. Effects of Inhibition of Glial Metabolism by Fluoroacetate. J. Cereb. Blood Flow Metab. 1997, 17, 1230–1238. [Google Scholar] [CrossRef] [PubMed]
  20. Zielke, H.R.; Collins, R.M.; Baab, P.J.; Huang, Y.; Zielke, C.L.; Tildon, J.T. Compartmentation of [14C]Glutamate and [14C]Glutamine Oxidative Metabolism in the Rat Hippocampus as Determined by Microdialysis. J. Neurochem. 2002, 71, 1315–1320. [Google Scholar] [CrossRef] [PubMed]
  21. Plaitakis, A.; Shashidharan, P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: Implications for the pathogenesis of Parkinson’s disease. J. Neurol. 2000, 247, II25–II35. [Google Scholar] [CrossRef] [PubMed]
  22. Cooper, A.J.; Plum, F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 1987, 67, 440–519. [Google Scholar] [CrossRef]
  23. McNeil, C.J.; Hoskin, S.O.; Bremner, D.M.; Holtrop, G.; Lobley, G.E. Whole-body and splanchnic amino acid metabolism in sheep during an acute endotoxin challenge. Br. J. Nutr. 2016, 116, 211–222. [Google Scholar] [CrossRef] [PubMed]
  24. Lochmiller, R.L.; Deerenberg, C. Trade-offs in evolutionary immunology: Just what is the cost of immunity? Oikos 2000, 88, 87–98. [Google Scholar] [CrossRef]
  25. Johnson, R.W. Fueling the immune response: What’s the cost? In Feed Efficiency in Swine; Springer: Berlin/Heidelberg, Germany, 2012; pp. 211–223. ISBN 978-90-8686-756-1. [Google Scholar]
  26. Meng, M.; Huo, R.; Wang, Y.; Ma, N.; Shi, X.; Shen, X.; Chang, G. Lentinan inhibits oxidative stress and alleviates LPS-induced inflammation and apoptosis of BMECs by activating the Nrf2 signaling pathway. Int. J. Biol. Macromol. 2022, 222, 2375–2391. [Google Scholar] [CrossRef]
  27. Huang, Y.; Shen, L.; Jiang, J.; Xu, Q.; Luo, Z.; Luo, Q.; Yu, S.; Yao, X.; Ren, Z.; Hu, Y.; et al. Metabolomic Profiles of Bovine Mammary Epithelial Cells Stimulated by Lipopolysaccharide. Sci. Rep. 2019, 9, 19131. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, J.P.; Yang, J.; Jiao, P.; Ren, Q.Q.; Luoreng, Z.M.; Wang, X.P.; Ma, Y.; Wei, D.W. Differential expression of circRNAs related to lipopolysaccharide-induced inflammation in bovine mammary epithelial cells. Res. Vet. Sci. 2022, 146, 24–27. [Google Scholar] [CrossRef]
  29. Zhan, K.; Yang, T.; Feng, B.; Zhu, X.; Chen, Y.; Huo, Y.; Zhao, G. The protective roles of tea tree oil extracts in bovine mammary epithelial cells and polymorphonuclear leukocytes. J. Anim. Sci. Biotechnol. 2020, 11, 62. [Google Scholar] [CrossRef]
  30. Zhang, M.C.; Zhao, S.G.; Wang, S.S.; Luo, C.C.; Gao, H.N.; Zheng, N.; Wang, J.Q. d-Glucose and amino acid deficiency inhibits casein synthesis through JAK2/STAT5 and AMPK/mTOR signaling pathways in mammary epithelial cells of dairy cows. J. Dairy Sci. 2018, 101, 1737–1746. [Google Scholar] [CrossRef] [PubMed]
  31. Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  32. Hoffmann, J.A.; Kafatos, F.C.; Janeway, C.A.; Ezekowitz, R.A.B. Phylogenetic Perspectives in Innate Immunity. Science 1999, 284, 1313–1318. [Google Scholar] [CrossRef] [PubMed]
  33. Bannerman, D.D.; Paape, M.J.; Lee, J.W.; Zhao, X.; Hope, J.C.; Rainard, P. Escherichia coli and Staphylococcus aureus Elicit Differential Innate Immune Responses following Intramammary Infection. Clin. Vaccine Immunol. 2004, 11, 463–472. [Google Scholar] [CrossRef] [PubMed]
  34. Dinarello, C.A.; Rietschel, E.T.; Wagner, H. Cytokines as Mediators in the Pathogenesis of Septic Shock. In Pathology of Septic Shock; Springer: Berlin/Heidelberg, Germany, 1996; Volume 216, pp. 133–165. ISBN 978-3-642-80188-4. [Google Scholar]
  35. Suffredini, A.F.; Fantuzzi, G.; Badolato, R.; Oppenheim, J.J.; O’Grady, N.P. New insights into the biology of the acute phase response. J. Clin. Immunol. 1999, 19, 203–214. [Google Scholar] [CrossRef]
  36. Dienz, O.; Rud, J.G.; Eaton, S.M.; Lanthier, P.A.; Burg, E.; Drew, A.; Bunn, J.; Suratt, B.T.; Haynes, L.; Rincon, M. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012, 5, 258–266. [Google Scholar] [CrossRef] [PubMed]
  37. Van Der Poll, T.; Lowry, S.F. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 1995, 3, 1–12. [Google Scholar] [CrossRef]
  38. Kan, X.; Liu, J.; Chen, Y.; Guo, W.; Xu, D.; Cheng, J.; Cao, Y.; Yang, Z.; Fu, S. Protective effect of myricetin on LPS-induced mastitis in mice through ERK1/2 and p38 protein author. Naunyn. Schmiedebergs Arch. Pharmacol. 2021, 394, 1727–1735. [Google Scholar] [CrossRef] [PubMed]
  39. Che, H.Y.; Zhou, C.H.; Lyu, C.C.; Meng, Y.; He, Y.T.; Wang, H.Q.; Wu, H.Y.; Zhang, J.B.; Yuan, B. Allicin Alleviated LPS-Induced Mastitis via the TLR4/NF-κB Signaling Pathway in Bovine Mammary Epithelial Cells. Int. J. Mol. Sci. 2023, 24, 3805. [Google Scholar] [CrossRef]
  40. Wang, W.; Hu, X.; Shen, P.; Zhang, N.; Fu, Y. Sodium houttuyfonate inhibits LPS-induced inflammatory response via suppressing TLR4/NF-ĸB signaling pathway in bovine mammary epithelial cells. Microb. Pathog. 2017, 107, 12–16. [Google Scholar] [CrossRef]
  41. Dong, Y.; An, D.; Wang, J.; Liu, H.; Zhang, Q.; Zhao, J.; Lu, W. Effect of DNA Methylation on LPS-Induced Expression of Tumour Necrosis Factor Alpha (TNF-α) in Bovine Mammary Epithelial Cells. Indian J. Anim. Res. 2021, 55, 1079–1084. [Google Scholar] [CrossRef]
  42. Zhang, J.Y.; Song, J.T.; Li, W.; Zhuang, Y.L.; Li, C.Z.; Song, W.H. Effects of Glucose on Expression of Inflammation Related Genes in Dairy Cow Mammary Epithelial Cells Stimulated by Lipopolysaccharide. Chin. J. Anim. Nutr. 2022, 34, 7350–7360. [Google Scholar] [CrossRef]
  43. Zarrin, M.; Wellnitz, O.; Van Dorland, H.A.; Gross, J.J.; Bruckmaier, R.M. Hyperketonemia during lipopolysaccharide-induced mastitis affects systemic and local intramammary metabolism in dairy cows. J. Dairy Sci. 2014, 97, 3531–3541. [Google Scholar] [CrossRef]
  44. Pires, J.A.A.; Pawlowski, K.; Rouel, J.; Delavaud, C.; Foucras, G.; Germon, P.; Leroux, C. Undernutrition modified metabolic responses to intramammary lipopolysaccharide but had limited effects on selected inflammation indicators in early-lactation cows. J. Dairy Sci. 2019, 102, 5347–5360. [Google Scholar] [CrossRef] [PubMed]
  45. Enger, B.D. Invited Review: Reevaluating how mastitis reduces milk yield: Discussion of competitive substrate utilization. Appl. Anim. Sci. 2019, 35, 408–415. [Google Scholar] [CrossRef]
  46. Bickerstaffe, R.; Annison, E.F.; Linzell, J.L. The metabolism of glucose, acetate, lipids and amino acids in lactating dairy cows. J. Agric. Sci. 1974, 82, 71–85. [Google Scholar] [CrossRef]
  47. Drackley, J.K.; Dann, H.M.; Douglas, N.; Guretzky, N.A.J.; Litherland, N.B.; Underwood, J.P.; Loor, J.J. Physiological and pathological adaptations in dairy cows that may increase susceptibility to periparturient diseases and disorders. Ital. J. Anim. Sci. 2005, 4, 323–344. [Google Scholar] [CrossRef]
  48. Gross, J.; Van Dorland, H.A.; Schwarz, F.J.; Bruckmaier, R.M. Endocrine changes and liver mRNA abundance of somatotropic axis and insulin system constituents during negative energy balance at different stages of lactation in dairy cows. J. Dairy Sci. 2011, 94, 3484–3494. [Google Scholar] [CrossRef] [PubMed]
  49. Suriyasathaporn, W.; Heuer, C.; Noordhuizen-Stassen, E.N.; Schukken, Y.H. Hyperketonemia and the impairment of udder defense: A review. Vet. Res. 2000, 31, 397–412. [Google Scholar] [CrossRef]
  50. Van Dorland, H.A.; Richter, S.; Morel, I.; Doherr, M.G.; Castro, N.; Bruckmaier, R.M. Variation in hepatic regulation of metabolism during the dry period and in early lactation in dairy cows. J. Dairy Sci. 2009, 92, 1924–1940. [Google Scholar] [CrossRef]
  51. Ingvartsen, K.L. Feeding- and management-related diseases in the transition cow. Anim. Feed Sci. Technol. 2006, 126, 175–213. [Google Scholar] [CrossRef]
  52. Pyrl, S. Mastitis in Post-Partum Dairy Cows. Reprod. Domest. Anim. 2008, 43, 252–259. [Google Scholar] [CrossRef]
  53. Shuster, D.E.; Lee, E.K.; Kehrli, M.E. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Am. J. Vet. Res. 1996, 57, 1569–1575. [Google Scholar] [PubMed]
  54. Gong, X.X.; Su, X.S.; Zhan, K.; Zhao, G.Q. The protective effect of chlorogenic acid on bovine mammary epithelial cells and neutrophil function. J. Dairy Sci. 2018, 101, 10089–10097. [Google Scholar] [CrossRef] [PubMed]
  55. Li, X.P.; Tan, Z.L.; Jiao, J.Z.; Long, D.L.; Zhou, C.S.; Yi, K.L.; Liu, C.H.; Kang, J.H.; Wang, M.; Duan, F.H.; et al. Supplementation with fat-coated rumen-protected glucose during the transition period enhances milk production and influences blood biochemical parameters of liver function and inflammation in dairy cows. Anim. Feed Sci. Technol. 2019, 252, 92–102. [Google Scholar] [CrossRef]
  56. Burvenich, C.; Bannerman, D.D.; Lippolis, J.D.; Peelman, L.; Nonnecke, B.J.; Kehrli, M.E.; Paape, M.J. Cumulative Physiological Events Influence the Inflammatory Response of the Bovine Udder to Escherichia coli Infections During the Transition Period. J. Dairy Sci. 2007, 90, E39–E54. [Google Scholar] [CrossRef]
  57. Paape, M.J.; Bannerman, D.D.; Zhao, X.; Lee, J.W. The bovine neutrophil: Structure and function in blood and milk. Vet. Res. 2003, 34, 597–627. [Google Scholar] [CrossRef]
  58. Ebner, K.E.; Schanbacher, F.L. Biochemistry of Lactose and Related Carbohydrates. In Biosynthesis and Secretion of Milk/Diseases; Academic Press: Cambridge, MA, USA, 1974; pp. 77–113. ISBN 978-0-12-436702-9. [Google Scholar]
  59. Cant, J.P.; Trout, D.R.; Qiao, F.; Purdie, N.G. Milk Synthetic Response of the Bovine Mammary Gland to an Increase in the Local Concentration of Arterial Glucose. J. Dairy Sci. 2002, 85, 494–503. [Google Scholar] [CrossRef]
  60. Zhao, K.; Liu, H.Y.; Wang, H.F.; Zhou, M.M.; Liu, J.X. Effect of glucose availability on glucose transport in bovine mammary epithelial cells. Animal 2012, 6, 488–493. [Google Scholar] [CrossRef] [PubMed]
  61. Kent-Dennis, C.; Aschenbach, J.R.; Griebel, P.J.; Penner, G.B. Effects of lipopolysaccharide exposure in primary bovine ruminal epithelial cells. J. Dairy Sci. 2020, 103, 9587–9603. [Google Scholar] [CrossRef]
  62. Zhao, F.Q.; Dixon, W.T.; Kennelly, J.J. Localization and gene expression of glucose transporters in bovine mammary gland. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1996, 115, 127–134. [Google Scholar] [CrossRef]
  63. Zhao, F.Q.; Miller, P.J.; Wall, E.H.; Zheng, Y.C.; Dong, B.; Neville, M.C.; McFadden, T.B. Bovine glucose transporter GLUT8: Cloning, expression, and developmental regulation in mammary gland. Biochim. Biophys. Acta BBA-Gene Struct. Expr. 2004, 1680, 103–113. [Google Scholar] [CrossRef]
  64. Lin, Y.; Sun, X.; Hou, X.; Qu, B.; Gao, X.; Li, Q. Effects of glucose on lactose synthesis in mammary epithelial cells from dairy cow. BMC Vet. Res. 2016, 12, 81. [Google Scholar] [CrossRef] [PubMed]
  65. Zhang, Z.; Zi, Z.; Lee, E.E.; Zhao, J.; Contreras, D.C.; South, A.P.; Abel, E.D.; Chong, B.F.; Vandergriff, T.; Hosler, G.A.; et al. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat. Med. 2018, 24, 617–627. [Google Scholar] [CrossRef]
  66. Corcoran, S.E.; O’Neill, L.A.J. HIF1α and metabolic reprogramming in inflammation. J. Clin. Investig. 2016, 126, 3699–3707. [Google Scholar] [CrossRef] [PubMed]
  67. Zhang, S.; Bories, G.; Lantz, C.; Emmons, R.; Becker, A.; Liu, E.; Abecassis, M.M.; Yvan-Charvet, L.; Thorp, E.B. Immunometabolism of Phagocytes and Relationships to Cardiac Repair. Front. Cardiovasc. Med. 2019, 6, 42. [Google Scholar] [CrossRef]
  68. Xiao, C.T.; Cant, J.P. Relationship Between Glucose Transport and Metabolism in Isolated Bovine Mammary Epithelial Cells. J. Dairy Sci. 2005, 88, 2794–2805. [Google Scholar] [CrossRef] [PubMed]
  69. Singh, K.V.; Sharma, D.; Singh, S.K.; Srivastava, M.; Garg, S.K.; Yadav, B.K. Assessment of alteration in metabolic profile and milk composition of buffaloes with subclinical mastitis. BUFFALO Bull. 2017, 36, 349–356. [Google Scholar]
  70. Li, P.; Yin, Y.L.; Li, D.; Woo Kim, S.; Wu, G. Amino acids and immune function. Br. J. Nutr. 2007, 98, 237–252. [Google Scholar] [CrossRef]
  71. Holeček, M. Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements. Nutr. Metab. 2018, 15, 33. [Google Scholar] [CrossRef]
  72. Wu, S.; Liu, X.; Cheng, L.; Wang, D.; Qin, G.; Zhang, X.; Zhen, Y.; Wang, T.; Sun, Z. Protective Mechanism of Leucine and Isoleucine against H2O2-Induced Oxidative Damage in Bovine Mammary Epithelial Cells. Oxid. Med. Cell. Longev. 2022, 2022, 4013575. [Google Scholar] [CrossRef]
  73. Kuhla, B.; Nürnberg, G.; Albrecht, D.; Görs, S.; Hammon, H.M.; Metges, C.C. Involvement of skeletal muscle protein, glycogen, and fat metabolism in the adaptation on early lactation of dairy cows. J. Proteome Res. 2011, 10, 4252–4262. [Google Scholar] [CrossRef] [PubMed]
  74. Leal Yepes, F.A.; Mann, S.; Overton, T.R.; Ryan, C.M.; Bristol, L.S.; Granados, G.E.; Nydam, D.V.; Wakshlag, J.J. Effect of rumen-protected branched-chain amino acid supplementation on production- and energy-related metabolites during the first 35 days in milk in Holstein dairy cows. J. Dairy Sci. 2019, 102, 5657–5672. [Google Scholar] [CrossRef] [PubMed]
  75. Wu, G. Functional amino acids in nutrition and health. Amino Acids. 2013, 45, 407–411. [Google Scholar] [CrossRef]
  76. Aschenbach, J.R.; Kristensen, N.B.; Donkin, S.S.; Hammon, H.M.; Penner, G.B. Gluconeogenesis in dairy cows: The secret of making sweet milk from sour dough. IUBMB Life 2010, 62, 869–877. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Effects of glucose concentrations on inflammation regulation and inflammatory cytokine gene expression of LPS-induced BMECs. BMECs were treated with 4 μg/mL LPS and different concentrations of glucose (2.5 and 17.5 mM). After incubation, the cells were collected for qRT-PCR. (A) IL-1β, (B) IL-6, (C) TNF-α, (D) CXCL2, (E) CXCL6, (F) CXCL8, and (G) CCL5. LG, low-glucose (2.5 mM) DMEM; LG + LPS, low-glucose (2.5 mM) DMEM with 4 μg/mL LPS; HG, high-glucose (17.5 mM) DMEM; HG + LPS, high-glucose (17.5 mM) DMEM with 4 μg/mL LPS; A, LPS addition; B, glucose content; A × B, interaction between LPS and glucose content. Different lowercase letters (a–d) in the bar chart indicate significant differences (p < 0.05).
Figure 1. Effects of glucose concentrations on inflammation regulation and inflammatory cytokine gene expression of LPS-induced BMECs. BMECs were treated with 4 μg/mL LPS and different concentrations of glucose (2.5 and 17.5 mM). After incubation, the cells were collected for qRT-PCR. (A) IL-1β, (B) IL-6, (C) TNF-α, (D) CXCL2, (E) CXCL6, (F) CXCL8, and (G) CCL5. LG, low-glucose (2.5 mM) DMEM; LG + LPS, low-glucose (2.5 mM) DMEM with 4 μg/mL LPS; HG, high-glucose (17.5 mM) DMEM; HG + LPS, high-glucose (17.5 mM) DMEM with 4 μg/mL LPS; A, LPS addition; B, glucose content; A × B, interaction between LPS and glucose content. Different lowercase letters (a–d) in the bar chart indicate significant differences (p < 0.05).
Animals 13 03494 g001
Figure 2. Effects of glucose concentrations on glucose metabolism gene expression and glucose consumption of LPS-induced BMECs. BMECs were treated with 4 μg/mL LPS and different concentrations of glucose (2.5 and 17.5 mM). After incubation, the cells were collected for qRT-PCR and the supernatant was collected to determine the content of glucose. (A) GLUT1, (B) GLUT8, (C) HK1, (D) HK2, (E) LDHA, and (F) glucose consumption. LG, low-glucose (2.5 mM) DMEM; LG + LPS, low-glucose (2.5 mM) DMEM with 4 μg/mL LPS; HG, high-glucose (17.5 mM) DMEM; HG + LPS, high-glucose (17.5 mM) DMEM with 4 μg/mL LPS; A, LPS addition; B, glucose content; A × B, interaction between LPS and glucose content. Different lowercase letters (a–c) in the bar chart indicate significant differences (p < 0.05).
Figure 2. Effects of glucose concentrations on glucose metabolism gene expression and glucose consumption of LPS-induced BMECs. BMECs were treated with 4 μg/mL LPS and different concentrations of glucose (2.5 and 17.5 mM). After incubation, the cells were collected for qRT-PCR and the supernatant was collected to determine the content of glucose. (A) GLUT1, (B) GLUT8, (C) HK1, (D) HK2, (E) LDHA, and (F) glucose consumption. LG, low-glucose (2.5 mM) DMEM; LG + LPS, low-glucose (2.5 mM) DMEM with 4 μg/mL LPS; HG, high-glucose (17.5 mM) DMEM; HG + LPS, high-glucose (17.5 mM) DMEM with 4 μg/mL LPS; A, LPS addition; B, glucose content; A × B, interaction between LPS and glucose content. Different lowercase letters (a–c) in the bar chart indicate significant differences (p < 0.05).
Animals 13 03494 g002
Table 1. Primers for real-time PCR analyses.
Table 1. Primers for real-time PCR analyses.
GenePrimer Sequence, 5′ to 3′Accession NumberSize (bp)
GAPDHF: GGGTCATCATCTCTGCACCT
R: GGTCATAAGTCCCTCCACGA
NM_001034034.2176
IL-1βF: CAGTGCCTACGCACATGTCT
R: AGAGGAGGTGGAGAGCCTTC
NM_174093.1209
IL-6F: CACCCCAGGCAGACTACTTCNM_173923.2129
R: TCCTTGCTGCTTTCACACTC
TNF-αF: GCCCTCTGGTTCAGACACTC
R: AGATGAGGTAAAGCCCGTCA
NM_173966.3192
CXCL2F: CCCGTGGTCAACGAACTGCGCTGC
R: CTAGTTTAGCATCTTATCGATGATT
NM_174299.3204
CXCL6F: TGAGACTGCTATCCAGCCG
R: AGATCACTGACCGTTTTGGG
NM_174300.2193
CXCL8F: TGGGCCACACTGTGAAAAT
R: TCATGGATCTTGCTTCTCAGC
NM_173925.2136
CCL5F: CTGCCTTCGCTGTCCTCCTGATG
R: TTCTCTGGGTTGGCGCACACCTG
NM_175827217
GLUT1F: CGTGCTCCTGGTTCTGTTCT
R: GGAACAGCTCCTCAGGTGTC
NM_001274304.1137
GLUT8F: AGTGACTGCCCGTCCTTGCT
R: TGCTGTCCTGGCTCCTGACT
NM_201528.1133
HK1F: GTGTGCTGTTGATAATCTCC
R: AATAACTGTTGGACGAATGC
NM_001012668.2149
HK2F: AAGATGCTGCCCACCTACG
R: TCGCTTCCCGTTCCGCACA
XM_015473383.2123
F, forward; R, reverse.
Table 2. Effects of glucose concentrations on amino acid uptake of LPS-induced BMECs.
Table 2. Effects of glucose concentrations on amino acid uptake of LPS-induced BMECs.
Treatment 1 p-Value 2
ItemLGLG + LPSHGHG + LPSSEMABA × B
Lysine0.29380.35660.09890.11840.0340.077<0.0010.318
Tryptophan0.03120.03660.01160.01530.0030.025<0.0010.633
Phenylalanine0.11410.16060.05990.06550.0140.1920.0040.295
Leucine0.1683 b0.2226 a0.0999 d0.1312 c0.015<0.001<0.0010.034
Isoleucine0.2620 b0.3409 a0.1041 c0.1162 c0.0300.004<0.0010.021
Methionine0.02400.02760.02970.03970.0010.0040.0010.101
Valine0.2001 b0.2785 a0.1081 c0.1226 c0.0230.004<0.0010.024
Tyrosine0.05890.06260.05940.06570.0020.4530.7820.842
Proline0.10330.12070.04830.05160.0090.136<0.0010.292
Threonine0.23470.26850.14270.15220.0170.219<0.0010.475
Arginine0.32850.33670.11750.14950.0320.445<0.0010.647
Histidine0.0960 b0.1786 a0.0423 c0.0467 c0.0160.001<0.0010.002
Glycine0.17610.20670.06020.06740.0200.103<0.0010.288
Serine0.13190.14270.05790.07140.0110.266<0.0010.857
Glutamate0.01730.02860.01200.01900.0010.0010.0030.263
1 LG = low-glucose (2.5 mM) DMEM; LG + LPS = low-glucose (2.5 mM) DMEM with 4 μg/mL LPS; HG = high-glucose (17.5 mM) DMEM; HG + LPS = high-glucose (17.5 mM) DMEM with 4 μg/mL LPS. 2 A = LPS addition; B = glucose content; A × B = interaction between LPS and glucose content. Different lowercase letters (a–d) in the bar chart indicate significant differences (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Song, H.; Lu, Z.; Zhan, K.; Datsomor, O.; Ma, X.; Yang, T.; Chen, Y.; Jiang, M.; Zhao, G. Effects of Glucose Levels on Inflammation and Amino Acid Utilization in Lipopolysaccharide-Induced Bovine Mammary Epithelial Cells. Animals 2023, 13, 3494. https://doi.org/10.3390/ani13223494

AMA Style

Song H, Lu Z, Zhan K, Datsomor O, Ma X, Yang T, Chen Y, Jiang M, Zhao G. Effects of Glucose Levels on Inflammation and Amino Acid Utilization in Lipopolysaccharide-Induced Bovine Mammary Epithelial Cells. Animals. 2023; 13(22):3494. https://doi.org/10.3390/ani13223494

Chicago/Turabian Style

Song, Han, Zhiqi Lu, Kang Zhan, Osmond Datsomor, Xiaoyu Ma, Tianyu Yang, Yuhang Chen, Maocheng Jiang, and Guoqi Zhao. 2023. "Effects of Glucose Levels on Inflammation and Amino Acid Utilization in Lipopolysaccharide-Induced Bovine Mammary Epithelial Cells" Animals 13, no. 22: 3494. https://doi.org/10.3390/ani13223494

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop